JP2022537914A5 - - Google Patents

Info

Publication number
JP2022537914A5
JP2022537914A5 JP2021572057A JP2021572057A JP2022537914A5 JP 2022537914 A5 JP2022537914 A5 JP 2022537914A5 JP 2021572057 A JP2021572057 A JP 2021572057A JP 2021572057 A JP2021572057 A JP 2021572057A JP 2022537914 A5 JP2022537914 A5 JP 2022537914A5
Authority
JP
Japan
Prior art keywords
fragment
apolipoprotein
amino acid
nerve cells
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021572057A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022537914A (ja
Filing date
Publication date
Priority claimed from EP19183411.8A external-priority patent/EP3757121A1/en
Application filed filed Critical
Publication of JP2022537914A publication Critical patent/JP2022537914A/ja
Publication of JP2022537914A5 publication Critical patent/JP2022537914A5/ja
Pending legal-status Critical Current

Links

JP2021572057A 2019-06-28 2020-06-25 アポリポタンパク質e断片 Pending JP2022537914A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19183411.8 2019-06-28
EP19183411.8A EP3757121A1 (en) 2019-06-28 2019-06-28 Apolipoprotein e fragments
PCT/EP2020/067858 WO2020260471A1 (en) 2019-06-28 2020-06-25 Apolipoprotein e fragments

Publications (2)

Publication Number Publication Date
JP2022537914A JP2022537914A (ja) 2022-08-31
JP2022537914A5 true JP2022537914A5 (cg-RX-API-DMAC10.html) 2023-06-05

Family

ID=67225988

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021572057A Pending JP2022537914A (ja) 2019-06-28 2020-06-25 アポリポタンパク質e断片

Country Status (5)

Country Link
US (1) US20220251171A1 (cg-RX-API-DMAC10.html)
EP (2) EP3757121A1 (cg-RX-API-DMAC10.html)
JP (1) JP2022537914A (cg-RX-API-DMAC10.html)
CN (1) CN114008072A (cg-RX-API-DMAC10.html)
WO (1) WO2020260471A1 (cg-RX-API-DMAC10.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220127347A1 (en) * 2020-10-26 2022-04-28 The Regents Of The University Of California Inhibition of Tau Propagation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002239766B9 (en) * 2000-11-03 2007-04-05 The J. David Gladstone Institutes Methods of treating disorders related to apoE
WO2005051998A2 (en) * 2003-11-28 2005-06-09 Astrazeneca Ab Antibodies binding to a c-terminal fragment of apolipoprotein e
CA2791648A1 (en) * 2010-03-01 2011-09-09 The J. David Gladstone Institutes Antibody specific for apolipoprotein and methods of use thereof

Similar Documents

Publication Publication Date Title
JP2019518793A (ja) バリアントアデノ随伴ウイルスおよび使用方法
JP2006500910A5 (cg-RX-API-DMAC10.html)
JP2009544284A5 (cg-RX-API-DMAC10.html)
Fan et al. Genetic and clinical findings in a Chinese cohort of patients with collagen VI‐related myopathies
JP4383170B2 (ja) ヒストン脱アセチル化酵素9
JP2004535166A5 (cg-RX-API-DMAC10.html)
JP2005506047A5 (cg-RX-API-DMAC10.html)
WO2014110628A1 (en) Gene and mutations thereof associated with seizure disorders
US7666603B2 (en) Breast cancer related protein, gene encoding the same, and method of diagnosing breast cancer using the protein and gene
KR20190083110A (ko) 마약 중독 또는 금단증상 진단용 바이오마커 조성물 및 마약 중독 또는 금단증상 진단용 키트
EP2758077B1 (en) Compounds for use in the treatment of alzheimer's disease
Shu et al. Upregulated CEMIP promotes intervertebral disc degeneration via AP‐1‐mediated change in chromatin accessibility
EA008252B1 (ru) Антитело или антигенсвязывающий домен, специфически связывающиеся с полипептидом потенциалзависимого воротного ионного канала
WO2001081361B1 (en) Compositions and method for diagnosing and treating conditions, disorders, or diseases involving cell death
KR102285662B1 (ko) 우울증 동물모델 및 이를 이용한 우울증 예방 또는 치료용 약물 스크리닝 방법
KR20220107891A (ko) 퇴행성 뇌질환에서 zbtb16의 용도
JP2008509659A5 (cg-RX-API-DMAC10.html)
Sziraki Developing EasySci, a High-Throughput and Low-Cost Single-Cell Genomic Technique, to Study Aging and Alzheimer's Disease in Human and Mouse Brain
KR102166717B1 (ko) 세파로토신을 포함하는 연체동물의 번식 촉진용 조성물
KR101587923B1 (ko) Tdp―43 관련 질환 진단 마커
JP2006516888A5 (cg-RX-API-DMAC10.html)
US20240034765A1 (en) Scg2 neuropeptides and uses thereof
KR101863417B1 (ko) 원위 근육병의 진단용 바이오 마커 및 이의 용도
CN121362838A (zh) 一种干扰素基因刺激因子的分子标记及其应用
EP1889905A1 (en) Method for amelioration of disease condition induced by mood disorder